Eden Innovations $5.7m Entitlement Offer: A Sharper Look

Eden Innovations Ltd (ASX: EDE) has launched a non-renounceable entitlement offer exclusively for existing shareholders. The company aims to raise up to $5.7 million, for 1 new share at $0.035 for every 2 shares you held.

The proceeds are earmarked to fuel Eden’s global growth push, particularly the expansion and marketing of its EdenCrete® carbon nanotube concrete admixtures and its OptiBlend® dual-fuel technology. Both products target multi-billion-dollar industries where the need for sustainable, efficient solutions is only intensifying.

EdenCrete® Sales Surge: The Growth Story

The past three months have delivered results that demand attention:

• 114% jump in Q4 sales year-on-year across all EdenCrete® products
• 50% growth in FY25 sales, hitting A$2.3 million compared with FY24
• Back-to-back growth in both halves since January 2024
• A record-breaking quarter for Pz7 sales at $350k
• Twelve new ready-mix plant installations in Q4, lifting the global tally to 16 across Colorado, Ecuador, and Canada
• Pz7 production capacity ramped up by 500% through process optimisation

Hard data showing real adoption and momentum, especially with Holcim Group rolling out Pz7 plants and trialling EdenCrete® across the US, Ecuador, Canada, Mexico, and the UK.

Repairing the Balance Sheet: Debt Reduction Moves

Investors often ask the only question that matters: is the company repairing its balance sheet? The answer here is yes.

• Roughly $5 million in shareholder loans repaid through equity earlier this month
• Additional loans expected to be retired via the entitlement offer itself
• A US$5 million property sale in Georgia due in October 2025, which will eliminate around 70% of the iBorrow loan
• A second property in Colorado positioned for sale, expected to remove all remaining group debt

These transactions will sharpen Eden’s financial profile, cutting borrowing costs and freeing cash for operations and growth.

Why This Raise Matters

The raise isn’t simply plugging a funding gap. It’s about accelerating Eden’s broader strategy:

• Expansion of EdenCrete® Pz7, with trials and adoption stretching across multiple continents
• Commercialisation of EdenPlast®, targeting the US$600 billion plastics market, with first revenues expected inside a year
• Early-stage development of CNT battery electrodes and conductive coatings, adding longer-term blue-sky potential
• Driving toward positive cash flow inside 12 months, based on compounding sales growth

In short, the raise backs products that are already gaining traction and clears the financial decks for a more sustainable future.

Proven Global Adoption

EdenCrete® isn’t a science project. It is already:

• Approved for use in 21 US states, including in high-profile infrastructure projects
• In commercial contracts such as the Port of Savannah in the US
• Embedded in US road, bridge, wastewater, and stadium projects since 2017
• Under trial in the UK, India, Indonesia, and Australia

Every new approval and contract builds on Eden’s credibility as a sustainable infrastructure partner.

The Edge: Technology Meets Sustainability

Eden’s proprietary carbon nanotube and turquoise hydrogen process converts methane with zero CO₂ emissions. EdenCrete® itself lowers the carbon footprint of concrete by enabling up to 60% pozzolan substitution, while at the same time producing stronger, more durable structures. This makes it not just a green solution but a practical one that saves on future maintenance costs.

Other Commercial Strikes

• OptiBlend®: over 800 dual-fuel systems installed globally, particularly in data centres and oil and gas
• EdenPlast®: CNT-enriched plastics with significant near-term revenue potential
• Hythane®: hydrogen-enriched natural gas, gaining interest in India and other emerging markets

Each division carries its own growth profile, ensuring Eden is not tied to a single revenue stream.

Leadership and Alignment

The Eden board is anchored by Executive Chairman Gregory Solomon and Director Douglas Solomon, both founding figures with decades of corporate, legal, and governance experience. The directors hold approximately 40% of the company, with their own capital. That alignment ensures management decisions aren’t made in isolation but with shareholder value front and centre.

About Eden Innovations

Eden Innovations Ltd (ASX:EDE) is an Australian-founded company at the intersection of infrastructure, sustainability, and clean technology. Its flagship product, EdenCrete®, is a carbon nanotube–enriched liquid admixture making concrete stronger, longer-lasting, and significantly reducing its CO₂ footprint. Beyond concrete, Eden owns 100% of its technologies, including OptiBlend®, EdenPlast®, and Hythane®, each targeting large and growing global markets.

With approvals in 21 US states, commercial traction in multiple countries, and a clear pathway to positive cash flow, Eden accelerating its growth story.

Frequently Asked Questions

1. How will the $5.7 million raised be used?
Funds are earmarked to accelerate global sales of EdenCrete® and expand Pz7 production, progress commercialisation of EdenPlast®, and strengthen the balance sheet by repaying debt. The raise is designed to position Eden for positive cash flow inside 12 months.

2. What progress has EdenCrete® made in the United States?
EdenCrete® is now approved in 21 US states and has been specified in roads, bridges, wastewater plants, and stadiums. The June quarter delivered record sales growth with 12 new ready-mix plants installed, many under global supplier Holcim.

3. Is the company reducing its debt load?
Yes. Roughly $5 million in shareholder loans were retired in July through equity, with more expected from entitlement offer participation. In addition, a US$5 million property sale in Georgia is due in October 2025 to repay around 70% of the iBorrow loan. A second property in Colorado is flagged to eliminate the remaining debt.

4. Do the directors have skin in the game?
Directors and founders together hold around 40% of Eden’s shares. They have consistently backed the company with their own capital, including loans and equity support. Their interests are directly aligned with retail investors in driving Eden toward debt reduction, sales growth, and positive cash flow.